Mirae Asset Global Investments’s Y-mAbs Therapeutics YMAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.89K | Buy |
1,750
+245
| +16% | +$1.11K | ﹤0.01% | 1516 |
|
|
2025
Q1 | $7.24K | Buy |
1,505
+12
| +0.8% | +$58 | ﹤0.01% | 1495 |
|
|
2024
Q4 | $11.9K | Sell |
1,493
-119
| -7% | -$952 | ﹤0.01% | 1493 |
|
|
2024
Q3 | $20.9K | Buy |
1,612
+302
| +23% | +$3.91K | ﹤0.01% | 1429 |
|
|
2024
Q2 | $16.2K | Buy |
+1,310
| New | +$16.2K | ﹤0.01% | 1409 |
|
|
2024
Q1 | – | Sell |
-26,090
| Closed | -$178K | – | 2669 |
|
|
2023
Q4 | $178K | Buy |
26,090
+1,089
| +4% | +$7.43K | ﹤0.01% | 2359 |
|
|
2023
Q3 | $136K | Hold |
25,001
| – | – | ﹤0.01% | 2394 |
|
|
2023
Q2 | $170K | Buy |
+25,001
| New | +$170K | ﹤0.01% | 2390 |
|
|
2023
Q1 | – | Sell |
-17,930
| Closed | -$87.5K | – | 2585 |
|
|
2022
Q4 | $87.5K | Buy |
17,930
+2,008
| +13% | +$9.8K | ﹤0.01% | 2469 |
|
|
2022
Q3 | $230K | Buy |
15,922
+4,736
| +42% | +$68.4K | ﹤0.01% | 2282 |
|
|
2022
Q2 | $169K | Buy |
+11,186
| New | +$169K | ﹤0.01% | 2193 |
|